two-pore domain potassium channel opener (Pfizer/Icagen)

N/A

Report date: 2025/06/11 10:30:06
NME

Base Information

Drug Nametwo-pore domain potassium channel opener (Pfizer/Icagen)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPotassium channel agonists
TargetsPotassium channel
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncIcagen Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A